{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:59:47Z","timestamp":1793037587670,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010731","name":"CMU | Faculty of Medicine, Chiang Mai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01437-5","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:55:10Z","timestamp":1771336510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Machine learning\u2013based cfDNA fragmentation profiling using automated capillary electrophoresis for early detection of hepatocellular carcinoma"],"prefix":"10.1038","volume":"6","author":[{"given":"Sasimol","family":"Udomruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songphon","family":"Sutthitthasakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttida","family":"Bunsermvicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokwan","family":"Pinyopornpanish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumnoensun","family":"Pruksakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phasit","family":"Charoenkwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petlada","family":"Yongpitakwattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanlaya","family":"Khounkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3342-5213","authenticated-orcid":false,"given":"Thanapak","family":"Jaimalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treephum","family":"Duangsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhasiri","family":"Orrapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutpirat","family":"Moonmuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5351-9998","authenticated-orcid":false,"given":"Pitiporn","family":"Noisagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnat","family":"Pasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathacha","family":"Suksakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratikorn","family":"Gamngoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimpisa","family":"Teeyakasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaiyut","family":"Charoentum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarawut","family":"Kongkarnka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worakitti","family":"Lapisatepun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parunya","family":"Chaiyawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77, 1598\u20131606 (2022).","journal-title":"J. Hepatol."},{"key":"1437_CR2","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.21037\/jgo.2020.02.08","volume":"12","author":"H Samant","year":"2021","unstructured":"Samant, H., Amiri, H. S. & Zibari, G. B. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J. Gastrointest. Oncol. 12, S361\u2013s373 (2021).","journal-title":"J. Gastrointest. Oncol."},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14740\/jocmr4902","volume":"15","author":"E Calderon-Martinez","year":"2023","unstructured":"Calderon-Martinez, E. et al. Prognostic scores and survival rates by etiology of hepatocellular carcinoma: a review. J. Clin. Med. Res. 15, 200\u2013207 (2023).","journal-title":"J. Clin. Med. Res."},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn, P., Ahmed, A. & Kim, D. Current epidemiology in hepatocellular carcinoma. Expert Rev. Gastroenterol. Hepatol. 15, 1295\u20131307 (2021).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"1437_CR5","first-page":"294","volume":"47","author":"S Chonprasertsuk","year":"2017","unstructured":"Chonprasertsuk, S. & Vilaichone, R. K. Epidemiology and treatment of hepatocellular carcinoma in Thailand. Jpn J. Clin. Oncol. 47, 294\u2013297 (2017).","journal-title":"Jpn J. Clin. Oncol."},{"key":"1437_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","volume":"157","author":"F Kanwal","year":"2019","unstructured":"Kanwal, F. & Singal, A. G. Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology 157, 54\u201364 (2019).","journal-title":"Gastroenterology"},{"key":"1437_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","volume":"130","author":"BH Zhang","year":"2004","unstructured":"Zhang, B. H., Yang, B. H. & Tang, Z. Y. Randomized controlled trial of screening for hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 130, 417\u2013422 (2004).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1158\/1055-9965.EPI-20-0005","volume":"29","author":"ND Parikh","year":"2020","unstructured":"Parikh, N. D. et al. Biomarkers for the Early Detection of Hepatocellular Carcinoma. Cancer Epidemiol. Biomark. Prev. 29, 2495\u20132503 (2020).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1437_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.17998\/jlc.20.2.99","volume":"20","author":"HJ Park","year":"2020","unstructured":"Park, H. J. & Kim, S. Y. Imaging modalities for hepatocellular carcinoma surveillance: expanding horizons beyond ultrasound. J. Liver Cancer 20, 99\u2013105 (2020).","journal-title":"J. Liver Cancer"},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva, K. et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology 154, 1706\u20131718.e1701 (2018).","journal-title":"Gastroenterology"},{"key":"1437_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/cancers16030662","volume":"16","author":"E Francini","year":"2024","unstructured":"Francini, E., Nuzzo, P. V. & Fanelli, G. N. Cell-free DNA: unveiling the future of cancer diagnostics and monitoring. Cancers 16, 662 (2024).","journal-title":"Cancers"},{"key":"1437_CR12","volume":"3","author":"Q Gao","year":"2022","unstructured":"Gao, Q. et al. Circulating cell-free DNA for cancer early detection. Innovation 3, 100259 (2022).","journal-title":"Innovation"},{"key":"1437_CR13","doi-asserted-by":"publisher","unstructured":"Telekes, A. & Horv\u00e1th, A. The role of cell-free DNA in cancer treatment decision making. Cancers 14, https:\/\/doi.org\/10.3390\/cancers14246115 (2022).","DOI":"10.3390\/cancers14246115"},{"key":"1437_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tig.2023.01.004","volume":"39","author":"T Moser","year":"2023","unstructured":"Moser, T., K\u00fchberger, S., Lazzeri, I., Vlachos, G. & Heitzer, E. Bridging biological cfDNA features and machine learning approaches. Trends Genet. 39, 285\u2013307 (2023).","journal-title":"Trends Genet."},{"key":"1437_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35959-6","volume":"14","author":"Y An","year":"2023","unstructured":"An, Y. et al. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation. Nat. Commun. 14, 287 (2023).","journal-title":"Nat. Commun."},{"key":"1437_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209852119","volume":"119","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. Epigenetic analysis of cell-free DNA by fragmentomic profiling. Proc. Natl. Acad. Sci. USA 119, e2209852119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1437_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220982120","volume":"120","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs. Proc. Natl. Acad. Sci. USA 120, e2220982120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1437_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","volume":"164","author":"MW Snyder","year":"2016","unstructured":"Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M. & Shendure, J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 164, 57\u201368 (2016).","journal-title":"Cell"},{"key":"1437_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103455","volume":"166","author":"S Udomruk","year":"2021","unstructured":"Udomruk, S., Orrapin, S., Pruksakorn, D. & Chaiyawat, P. Size distribution of cell-free DNA in oncology. Crit. Rev. Oncol. Hematol. 166, 103455 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1437_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104962","volume":"100","author":"L Chen","year":"2024","unstructured":"Chen, L. et al. Cell-free DNA testing for early hepatocellular carcinoma surveillance. EBioMedicine 100, 104962 (2024).","journal-title":"EBioMedicine"},{"key":"1437_CR21","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/1878-0261.13041","volume":"15","author":"C Jin","year":"2021","unstructured":"Jin, C. et al. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection. Mol. Oncol. 15, 2377\u20132389 (2021).","journal-title":"Mol. Oncol."},{"key":"1437_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10681-0","volume":"23","author":"VC Nguyen","year":"2023","unstructured":"Nguyen, V. C. et al. Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma. BMC Cancer 23, 233 (2023).","journal-title":"BMC Cancer"},{"key":"1437_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.32308","volume":"76","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics. Hepatology 76, 317\u2013329 (2022).","journal-title":"Hepatology"},{"key":"1437_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13072-023-00508-4","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer. Epigenetics Chromatin 16, 33 (2023).","journal-title":"Epigenetics Chromatin"},{"key":"1437_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1073\/pnas.1815031116","volume":"116","author":"L Serpas","year":"2019","unstructured":"Serpas, L. et al. Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA. Proc. Natl. Acad. Sci. USA 116, 641\u2013649 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1437_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13273","volume":"55","author":"B Li","year":"2022","unstructured":"Li, B. et al. DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with \u03b2-catenin to promote its ubiquitin degradation pathway. Cell Prolif. 55, e13273 (2022).","journal-title":"Cell Prolif."},{"key":"1437_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1677-2","volume":"16","author":"M Lapin","year":"2018","unstructured":"Lapin, M. et al. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. J. Transl. Med. 16, 300 (2018).","journal-title":"J. Transl. Med."},{"key":"1437_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","volume":"570","author":"S Cristiano","year":"2019","unstructured":"Cristiano, S. et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385\u2013389 (2019).","journal-title":"Nature"},{"key":"1437_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/2159-8290.CD-22-0659","volume":"13","author":"ZH Foda","year":"2023","unstructured":"Foda, Z. H. et al. Detecting liver cancer using cell-free DNA fragmentomes. Cancer Discov. 13, 616\u2013631 (2023).","journal-title":"Cancer Discov."},{"key":"1437_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41551-025-01370-3","volume":"9","author":"G Zhu","year":"2025","unstructured":"Zhu, G. et al. A deep-learning model for quantifying circulating tumour DNA from the density distribution of DNA-fragment lengths. Nat. Biomed. Eng. 9, 307\u2013319 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"1437_CR31","unstructured":"WHO Screening criteria."},{"key":"1437_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig, M. et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J. Hepatol. 76, 681\u2013693 (2022).","journal-title":"J. Hepatol."},{"key":"1437_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.107952","volume":"50","author":"M Drefs","year":"2024","unstructured":"Drefs, M. et al. Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis. Eur. J. Surg. Oncol. 50, 107952 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"key":"1437_CR34","doi-asserted-by":"publisher","unstructured":"Toubert, C. et al. Prolonged survival after recurrence in HCC resected patients using repeated curative therapies: Never give up! Cancers 15, https:\/\/doi.org\/10.3390\/cancers15010232 (2022).","DOI":"10.3390\/cancers15010232"},{"key":"1437_CR35","first-page":"519","volume":"114","author":"MB Schoenberg","year":"2017","unstructured":"Schoenberg, M. B. et al. Resection or transplant in early hepatocellular carcinoma. Dtsch Arztebl Int 114, 519\u2013526 (2017).","journal-title":"Dtsch Arztebl Int"},{"key":"1437_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60379-x","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study. Sci. Rep. 14, 9745 (2024).","journal-title":"Sci. Rep."},{"key":"1437_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/cas.14679","volume":"112","author":"K Nakano","year":"2021","unstructured":"Nakano, K. et al. Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation. Cancer Sci. 112, 168\u2013177 (2021).","journal-title":"Cancer Sci."},{"key":"1437_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.14366\/usg.18051","volume":"38","author":"YY Kim","year":"2019","unstructured":"Kim, Y. Y. et al. Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits. Ultrasonography 38, 311\u2013320 (2019).","journal-title":"Ultrasonography"},{"key":"1437_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/02656736.2021.1933217","volume":"38","author":"SH Tsang","year":"2021","unstructured":"Tsang, S. H. et al. High-intensity focused ultrasound ablation of liver tumors in difficult locations. Int J. Hyperth. 38, 56\u201364 (2021).","journal-title":"Int J. Hyperth."},{"key":"1437_CR40","doi-asserted-by":"publisher","unstructured":"Hong, S. B. et al. Inadequate ultrasound examination in hepatocellular carcinoma surveillance: a systematic review and meta-analysis. J. Clin. Med. 10, https:\/\/doi.org\/10.3390\/jcm10163535 (2021).","DOI":"10.3390\/jcm10163535"},{"key":"1437_CR41","doi-asserted-by":"publisher","first-page":"e0256436","DOI":"10.1371\/journal.pone.0256436","volume":"16","author":"J Bredno","year":"2021","unstructured":"Bredno, J., Lipson, J., Venn, O., Aravanis, A. M. & Jamshidi, A. Clinical correlates of circulating cell-free DNA tumor fraction. PLoS One 16, e0256436 (2021).","journal-title":"PLoS One"},{"key":"1437_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1024193","volume":"9","author":"S Kumar","year":"2022","unstructured":"Kumar, S. et al. Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease. Front Mol. Biosci. 9, 1024193 (2022).","journal-title":"Front Mol. Biosci."},{"key":"1437_CR43","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ajcp\/aqac037","volume":"158","author":"R Elzehery","year":"2022","unstructured":"Elzehery, R. et al. Circulating cell-free DNA and DNA integrity as molecular diagnostic tools in hepatocellular carcinoma. Am. J. Clin. Pathol. 158, 254\u2013262 (2022).","journal-title":"Am. J. Clin. Pathol."},{"key":"1437_CR44","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.7150\/jca.15823","volume":"7","author":"A Huang","year":"2016","unstructured":"Huang, A. et al. Detecting circulating tumor DNA in hepatocellular carcinoma patients using droplet digital PCR is feasible and reflects intratumoral heterogeneity. J. Cancer 7, 1907\u20131914 (2016).","journal-title":"J. Cancer"},{"key":"1437_CR45","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3748\/wjg.v27.i17.2025","volume":"27","author":"DH Yang","year":"2021","unstructured":"Yang, D. H. et al. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: a retrospective cross-sectional study. World J. Gastroenterol. 27, 2025\u20132038 (2021).","journal-title":"World J. Gastroenterol."},{"key":"1437_CR46","doi-asserted-by":"publisher","unstructured":"Rabaan, A. A. et al. Prevalence of hepatocellular carcinoma in hepatitis B population within Southeast Asia: a systematic review and meta-analysis of 39,050 participants. Pathogens 12, https:\/\/doi.org\/10.3390\/pathogens12101220 (2023).","DOI":"10.3390\/pathogens12101220"},{"key":"1437_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.cgh.2017.08.042","volume":"16","author":"S Mittal","year":"2018","unstructured":"Mittal, S. et al. Role of age and race in the risk of hepatocellular carcinoma in veterans with hepatitis B virus infection. Clin. Gastroenterol. Hepatol. 16, 252\u2013259 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1437_CR48","doi-asserted-by":"publisher","unstructured":"Sachar, Y., Brahmania, M., Dhanasekaran, R. & Congly, S. E. Screening for hepatocellular carcinoma in patients with hepatitis B. Viruses 13, https:\/\/doi.org\/10.3390\/v13071318 (2021).","DOI":"10.3390\/v13071318"},{"key":"1437_CR49","doi-asserted-by":"publisher","unstructured":"Sutthitthasakul, S. Celiver: v1.0.0, <https:\/\/doi.org\/10.5281\/zenodo.18297357> (2026).","DOI":"10.5281\/zenodo.18297357"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01437-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01437-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01437-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:07:04Z","timestamp":1774541224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01437-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01437-5","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sasimol Udomruk, Songphon Sutthitthasakul, Worakitti Lapisatepun, and Parunya Chaiyawat report a petty patent application (Thai-2403001380) currently under review, licensed to CELiver, for the cfDNA-based automated capillary electrophoresis method for liver cancer screening. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}